Proliferating-Cell Nuclear Antigen Antibodies (PCNA)
Back to Test Catalogue
Proliferating-Cell Nuclear Antigen Antibodies (PCNA), Serum
Test ID: PCNA
Test
Method
Immunofluorescence Assay (IFA)
Report Includes
Specimens
Serum
Clinical Utility
Antibody to proliferating cell nuclear antigen (PCNA Ab) may be detected in a small subpopulation (3-5%) of SLE patients. They are highly SLE-specific and are associated with higher incidence of diffuse glomerulonephritis among SLE patients.
Test Location
Quest Diagnostics, California USA
Test Version
30-Sep-2019
Specimen
Specimens
Serum
Sample Volume
1.0 mL
Minimum Volume
0.5 mL
Specimen Comment
Gel-separator tubes are acceptable.
Collection & Handling
Handling Information
Store and send frozen.
Stability
| Ambient | 4 days |
|---|---|
| Refrigerated | 7 days |
| Frozen | 30 days |
Rejection Criteria
| Hemolysis | Gross |
|---|---|
| Lipemia | Present |
Test Version
30-Sep-2019
Performance / Interpretation
Method
Immunofluorescence Assay (IFA)
Turnaround Time
15 days
Results
| Name | Units | Reference Range | Conversion Factor | |
|---|---|---|---|---|
| PCNA Antibodies | Qualitative Test |
|
||
Test Location
Quest Diagnostics, California USA
Test Version
30-Sep-2019
Interface / Setup
Test Version
30-Sep-2019